In erythroid cells the vast majority of iron (Fe) released from endosomes must cross both the outer and the inner mitochondrial membranes to reach ferrochelatase that inserts Fe into protoporphyrin IX. In the present study, we developed a method whereby a cohort of 59 Fe-transferrin (Tf)-laden endosomal vesicles were generated, from which we could evaluate the transfer of 59 Fe into mitochondria. Iron chelators, dipyridyl or salicylaldehyde isonicotinoyl hydrazone (SIH), were able to bind the 59 Fe when they were present during a 37°C incubation; however, addition of these agents only during lysis at 4°C chelated virtually no 59 Fe. Bafilomycin A1 (which prevents endosome acidification) and succinylacetone (an inhibitor of 5-aminolevulinate dehydratase) prevented endosomal 59 Fe incorporation into heme. Importantly, both the myosin light chain kinase inhibitor wortmannin and the calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalene-sulfonamide (W-7), caused significant inhibition of 59 Fe incorporation from 59 Fe-Tf-labeled endosomes into heme, suggesting that myosin is required for Tf-vesicle movement.
IntroductionNormal hemoglobinization of immature erythroid cells requires iron uptake from transferrin (Tf), mediated by Tf receptors, whose high levels are essential for maintaining the exceptionally rapid rates of heme synthesis. On a per-cell basis the rate of heme synthesis in immature erythroid cells is at least an order of magnitude higher than in the liver, the second highest heme producer in the organism. 1 Following the binding of Fe(III) 2 -Tf to Tf receptors on the erythroid cell membrane, the Tf-receptor complexes are internalized by endocytosis, and iron is then released from Tf by a process involving endosomal acidification. [1][2][3] The transporter, Nramp2 (also known as DMT1 4 or DCT1 5 ), has been shown to be likely responsible for the egress of iron from the endosome. [6][7][8] This protein is encoded by a gene that belongs to the "natural resistance-associated macrophage protein" (Nramp) family of genes identified by Gros and his coworkers 9 and transports Fe(II). 5 Therefore, reduction of Fe(III) must occur in endosomes; however, nothing is known about the mechanism of this process. It is generally believed that following its release from endosomes, iron enters the cytosol where it equilibrates with a low molecular weight labile iron pool. 10,11 However, the extraordinary efficiency of Fe utilization in erythroid tissues, as well as the apparent targeting of Fe to mitochondria (as discussed in the next paragraph), may be inconsistent with such a model.In hemoglobin-synthesizing cells, the vast majority of iron released from endosomes must cross both the outer and the inner mitochondrial membranes to reach ferrochelatase. 1 It is remarkable that in these cells iron acquired from Tf continues to flow into mitochondria, even when the synthesis of protoporphyrin IX is markedly compromised in vitro (by isonicotinic acid hydrazide [INH] or succinylacetone [SA]) [12][13][14][15][16] or in...